Загрузка...
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key driver of atherosclerosis. Circulating biomarkers of inflammation, including high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6), are associated with increased risk of cardiovascular events...
Сохранить в:
| Опубликовано в: : | Front Cardiovasc Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6403155/ https://ncbi.nlm.nih.gov/pubmed/30873416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2019.00016 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|